Blogs | MedChemExpress

CP681301 is a Potent CDK5 Inhibitor

CP681301 is a potent CDK5 inhibitor, inhibits glioma stem cells self-renewal and shows anti-tumor activity.
Cabozantinib is a potent Multiple Receptor Tyrosine Kinases (RTKs) Inhibitor

Cabozantinib is a potent multiple receptor tyrosine kinases (RTKs) inhibitor with good anticancer activity.
Aderbasib is a Highly Potent and Orally Active Inhibitor of ADAM10 and ADAM17

Aderbasib is a potent and orally active inhibitor of ADAM10 and ADAM17. Aderbasib exhibits robust antineoplastic activity in vivo.
Nimotuzumab is a Humanized IgG1 Monoclonal Antibody Targeting EGFR

Nimotuzumab is a humanized IgG1 monoclonal antibody targeting EGFR. Nimotuzumab is a strong antitumor drug.
Vorasidenib (AG-881) is an Orally Available, Brain Penetrant and dual mIDH1/2 Inhibitor

Vorasidenib is an orally available, brain penetrant second-generation dual mutant isocitrate dehydrogenases 1 and 2 (mIDH1/2) inhibitor.
Lonafarnib is an Orally Active FPTase Inhibitor

Lonafarnib is a potent and orally active farnesyl transferase inhibitor, and it inhibits the activities of H-ras, K-ras and N-ras.
A-674563 is an Orally Active and Selective Akt1 Inhibitor

A-674563 is an orally active and selective Akt1 inhibitor. A-674563 induces G2 cell cycle arrest and apoptosis in STS cells.
BIM-23190 is a Selective SSTR2 and SSTR5 Agonist

BIM-23190, a somatostatin analog, is a selective SSTR2 and SSTR5 agonist. BIM-23190 can be used in the study for cancer and acromegaly.
AKI603 is an Aurora Kinase A Inhibitor with Anti-tumor Activity

AKI603 is a potent Aurora kinase inhibitor. AKI603 attenuates breast tumor-initiating cells and overcomes drug resistance.
G5-7, an Orally Active JAK2 Inhibitor, Induces Cell Cycle Arrest and Apoptosis

G5-7, an orally active and allosteric JAK2 inhibitor. G5-7 induces cell cycle arrest, apoptosis and possesses antiangiogenic effect.

Name
Email *

	Sorry, but the email address you supplied was invalid.

Blogs (13)